Cite
HARVARD Citation
Vickers, R. et al. (n.d.). Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Lancet infectious diseases. 17 (7), pp. 735-744. [Online].